Protein S deficiency with homozygous factor V Leiden mutation in central retinal vein occlusion [9]

Canadian Journal of Ophthalmology

Volumn 42, Issue 4, 2007, Pages 632-633

  Sucak, G T ^a   Aki, Z ^a   Or, M ^a  

^a GAZI UNIVERSITY FACULTY OF MEDICINE   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTEIN C; ANTICOAGULANT AGENT; HEPARIN; PROTEIN S; WARFARIN;

ADULT; CASE REPORT; CENTRAL RETINA VEIN OCCLUSION; CHEMICAL ANALYSIS; DRUG SUBSTITUTION; FEMALE; FLUORESCENCE ANGIOGRAPHY; HISTOPATHOLOGY; HUMAN; LETTER; MUTATION; OPHTHALMOSCOPY; OPTIC DISK; PATHOGENESIS; PROTEIN S DEFICIENCY; STATISTICAL SIGNIFICANCE; VEIN THROMBOSIS; VISUAL ACUITY;

EID: 34748860949     PISSN: 00084182     EISSN: 17153360     Source Type: Journal    
DOI: 10.3129/I07-107     Document Type: Letter

References (6)

1. Fegan CD. Central retinal vein occlusion and thrombophilia. Eye 2002;16:98-106.
2. Adamczuk YP, Iglesias Varela ML, Martinuzzo ME, Cerrato GS, Forastiero RR. Central retinal vein occlusion and thrombophilia risk factors. Blood Coag Fibrinol 2002;13:623-6.
3. Arsene S, Delahousse B, Regina S, Le Lez ML, Pisella PJ, Gruel Y. Increased prevalence of factor V Leiden in patients with retinal vein occlusion and under 60 years of age. Thromb Haemost 2005;94:101-6.
4. Filho PP, Pierre MM, Nascimento MA, Marcondes MA. Central retinal vein prethrombosis as an initial manifestation of protein S deficiency. Sau Paulo Med J 2004;122:134-5.
5. Backhouse O, Parapia L, Mahomed I, Lee D. Familial thrombophlia and retinal vein occlusion. Eye 2000;14:13-7.
6. Hvarfner C, Hillarp A, Larsson J. Influence of factor V Leiden on the development of neovascularization secondary to central retinal vein occlusion. Br J Ophthalmol 2003;87:305-6.